About Emory University School of Medicine- Human Genetics-Site Number:840060
Clinical Trials at Emory University School of Medicine- Human Genetics-Site Number:840060
During the past decade, Emory University School of Medicine- Human Genetics-Site Number:840060 conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on
average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Emory University School of Medicine- Human Genetics-Site Number:840060"
#1 collaborator was "Atlanta Clinical and Translational Science Institute" with 1 trials as a collaborator, "BioMarin Pharmaceutical" with 1 trials as a collaborator and "National PKU Alliance" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Emory University School of Medicine- Human Genetics-Site Number:840060
According to Clinical.Site data, the most researched conditions in "Emory University School of Medicine- Human Genetics-Site Number:840060" are
"Gaucher Disease" (4 trials), "Down Syndrome" (3 trials), "Gaucher Disease, Type 1" (2 trials), "Glycogen Storage Disease Type II" (2 trials) and "Autism Spectrum Disorder" (1 trials). Many other conditions were trialed in "Emory University School of Medicine- Human Genetics-Site Number:840060" in a lesser frequency.
Clinical Trials Intervention Types at Emory University School of Medicine- Human Genetics-Site Number:840060
Most popular intervention types in "Emory University School of Medicine- Human Genetics-Site Number:840060" are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Eliglustat tartrate" (2 trials), "Taliglucerase alfa" (2 trials), "Imiglucerase" (1 trials) and "KuvanTM Therapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Emory University School of Medicine- Human Genetics-Site Number:840060
The vast majority of trials in "Emory University School of Medicine- Human Genetics-Site Number:840060" are
15 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Emory University School of Medicine- Human Genetics-Site Number:840060
Currently, there are NaN active trials in "Emory University School of Medicine- Human Genetics-Site Number:840060".
undefined are not yet recruiting,
4 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Emory University School of Medicine- Human Genetics-Site Number:840060,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Emory University School of Medicine- Human Genetics-Site Number:840060, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".